Is there an association of uric acid level with preclinical target organ damage in moderate-and high-risk hypertensive patients?
- Authors: Dmitriev VA1, Oshchepkova EV1, Titov VN1, Rogoza AN1, Saidova MA1, Bolotova MN1, Gushchina OV1, Polevaia TI.1
-
Affiliations:
- Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
- Issue: Vol 85, No 9 (2013)
- Pages: 52-57
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31333
- ID: 31333
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V A Dmitriev
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
Email: vicdmi@mail.ru
E V Oshchepkova
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
V N Titov
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
A N Rogoza
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
M A Saidova
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
M N Bolotova
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
O V Gushchina
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
T Iu Polevaia
Институт клинической кардиологии им. А.Л. Мясникова РКНПК Минздрава России, Москва
References
- Bengtsson C., Lapidus L., Stendahl C. et al. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gotheburg, Sweden. Acta Med Scand 1988; 224: 549-555.
- Brand F.N. McGee D.L., Kennel W.B. Hyperuricemia as a risk factor of coronary heart disease: the Framinghem Heart Study. Am J Epidemiol 1985; 121 (1): 11-18.
- Freedman D., Williamson D., Gunter E. et al. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995; 141: 637-644.
- Gertler M.M., Garn S.M., Levine S.A. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med 1951; 34: 1421-1431.
- Isik T., Ayhan E., Ergelen M. et al. Uric acid: a novel prognostic marker for cardiovascular disease. Intern J Cardiol 2012; 156 (3): 328-329.
- Глезер М.Г., Бойко Н.В., Абильдинова А.Ж. и др. Факторы риска у московской популяции больных артериальной гипертонией. Рос кардиол журн 2002; 6: 16-23.
- Conen D., Wietlisbach V., Bovet P. et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9.
- Corry D.B., Eslami P. Yamamoto K. et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275.
- Krishnan E., Kwoh C.K., Schumacher H.R. et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49 (2): 298-303.
- Johnson R.J., Duk-Hee Kang, Feig D. et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
- Mazzali M., Hughes J., Kim Yoon-Goo et al. Elevated uric acid increases bloods pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-1106.
- Watanabe S., Kang D., Feng L. et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40 (3): 355-360.
- Johnson R., Feig D., Herera-Acosta J. et al. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45: 18-20.
- Mellen P., Bleyer A., Erlinger T. et al. Serum uric acid predicts incident hypertension in a biethnic cohort. The atherosclerosis risk in communities study. Hypertension 2006; 48: 1037-1042.
- Perlstein T., Gumeniak O., Williams G. et al. Uric Acid and the development of hypertension. The Normative Ageing Study. Hypertension 2006; 48: 1031-1036.
- Sundström J., Sulliva L., D`Agostino R., Levy D. et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28-33.
- Taverner D., Bing R., Fletcher A. et al. Hypertension produced by chemical medullectomy: Evidence for a renomedullary vasodepressor function in the rat. Clinl Sci 1984; 67: 521-528.
- Бритов А.Н., Деев А.Д., Балкаров И.М. Взаимосвязь артериальной гипертонии, обменных нарушений и уратной нефропатии. Тер арх 2006; 5: 41-45.
- Johnson R.J., Duk-Hee Kang, Feig D. et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
- Netea M., Rullberg B., Blok W. et al. The role of Hyperuricemia in the increased cytokine production after lipopolisaccharide challenge in neutropenic mice. Blood 1997; 89: 577-582.
- Nieto F., Gross M., Comstock G. et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-139.
- Venugopal S., Devarai S., Yuhanna I. et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106 (12): 1439-1441.
- Wang C., Szmitko P., Weisel R. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108 (16): 1917-1923.
- McCord J.M., Roy R.S., Schaffer S.W. Free radicals and myocardial ischemia. The role xanthine oxidase. Adv Myocardial 1985; 5: 183-189.
- Sanchez-Lozada L.G., Soto V., Tapia E. et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008; 295 (4): 1134-1141.
- Ames B.N., Cathcart R., Schwiers E. et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862.
- Hink H.U., Santanam N., Dikalov S. et al. Peroxidase properties of extracellular superoxidedismutase: role of uric acid in modulating in vivo activity. Arteriosclerosis Thrombos Vasc Biol 2002; 22: 1402-1408.
- Атюнина И.В., Ощепкова Е.В., Федорович А.А. и др. Мочевая кислота и функция эндотелия микроциркуляторного русла у больных на ранних стадиях артериальной гипертонии. Системные гипертензии 2012; 2: 29-33.
- Ощепкова Е.В. Дмитриев В.А., Половиткина О.В., Титов В.Н. Содержание мочевой кислоты и ее роль на ранних стадиях гипертонической болезни. Системные гипертензии 2009; 2: 51-54.
- Ощепкова Е.В., Дмитриев В.А., Титов В.Н. и др. Показатели неспецифичного воспаления у больных гипертонической болезнью. Тер арх 2007; 12: 18-25.
- Чазова И.Е., Ощепкова Е.В., Чихладзе Н.М. Артериальная гипертония. Принципы диагностики и лечения (пособие для врачей). М 2005: 35.
- Национальные рекомендации по диагностике и лечению артериальной гипертензии. ВНОК 2010 г., 4-й пересмотр: 9.
- Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values. The Reference Values for Arterial Stiffness' Collaboration. Eur Heart J 2010; 31: 2338-2350.
- Akpek M., Kaya M.G., Uyarel H. et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011; 219: 334-341.
- Ndrepepaa G., Brauna S., Kinga L. et al. Association of uric acid with mortality in patients with stable coronary artery disease. Metabolism 2012; 61 (12): 1780-1786.
- Chung-Sheng Lin, Yi-Jen Hung, Gau-Yang Chen et al. A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients. Intern J Cardiol 2011; 148: 325-330.
- Yihua Shen, Liangdi Xie, Lingue Zhang et al. Relationship between endothelium-dependent vasodilation and uric acid in essential hypertensive patients with LVH. Intern J Cardiol 2011; 152 (Suppl 1): s21.
- Perticone F., Maio R., Tassone J.E. et al. Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. Metabolism 2013; 167 (1): 232-236.
- Viazzi F., Parodi D., Leoncini G. et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-996.
- Mule G., Nardi E., Costanzo M. et al. Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive woman and men. Nutr, Metab Cardiovasc Dis 2012; 1-8 (in press).
- Strasak A., Ruttmann E., Brant L. et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83683 Austrian men. Clin Chem 2008; 54 (2): 273-284.
- Tsioufis C., Chatzis D., Vezali А. et al. The Controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. Am J Hypertension 2007; 20: 678-685.
- Kang D.K., Park S.K., Lee I.K. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562.
- Sanchez-Lozada L.G., Tapia E., Avila-Casado C. Soto V. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Renal Physiol 2002; 283: 1105-1110.
- Feig D.I., Duk-Hee Kang, Johnson R. Uric acid and cardiovascular risk. New Engl J Med 2008; 359: 1811-1821.
- Cheng T.H., Lin J.W., Chao H.H. et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Intern J Cardiol 2010; 139: 42-49.
- Corry D.B., Eslami P., Yamamoto K. et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275.
![](/img/style/loading.gif)